Mario SznolBA, MD
Dr. Mario Sznol graduated from RiceUniversity and Baylor College of Medicine (BCM) in Houston, Texas. He trained in internal medicine at BCM and completed a medical oncology fellowship in the Department of Neoplastic Diseases, Mount Sinai Hospital, New York. He spent the next twelve years in the Biologics Evaluation Section (BES), Investigational Drug Branch (IDB), Cancer Therapy Evaluation Program of the National Cancer Institute, and was Head of the BES from 1994-1999.
He attended in the Biological Response Modifiers Program, NCI, from 1988-1996 and on the Immunotherapy Service of the Surgery Branch, NCI, from 1997-1999. From 1999 to 2004 Dr. Sznol was a Vice President and Executive Officer of Vion Pharmaceuticals inNew Haven, CT. Dr. Sznol is currently Professor of Internal Medicine at Yale University School of Medicine, Clinical Translational Research Leader of the Melanoma Program, and co-Director of Yale SPORE in Skin Cancer.
Dr. Sznol was a member of the NCI Decision Network of the Division of Cancer Treatment and Diagnosis, NCI, 1994-1999, served as a member of the Investigational Drug Steering Committee (IDSC), NCI, and was former Chair of the Immunotherapy Task Force of the IDSC. He served on the Editorial Advisory Boards of the Journal of National Cancer Institute, Journal of Immunotherapy, Investigational New Drugs, and Journal of Translational Medicine. He was a Member of the Board of Directors, International Society for Biological Therapy of Cancer from 2003-2008.